White Paper on Consumer-Driven Health Plans Available Free to the Media from

                  Research Firm InterStudy Publications    What:        White paper entitled Consumer-Driven Health Plans: What,                When, and Why available free to the media    Who:         Tammy Lauer, lead author of white paper, will be available                to speak to media    How:         Available by phone and in person-St. Paul, Minnesota  

InterStudy Publications, a division of Decision Resources, Inc., is making available a new white paper analyzing the impact of consumer-driven health plans (CDHPs) on the managed care industry. The white paper is free to the media and can be obtained by contacting Frank Sama at InterStudy Publications at 781-296-2553 or fsama@dresources.com.

The paper focuses on the potential impact of consumer-driven health plans on employers and employees and concentrates specifically on the pros and cons of CDHPs. The paper evaluates the following:

  -- The current health care market   -- Consumer-driven health plans and some major models   -- Major players in the CDHP market   -- Future outlook for CDHPs  

Lead author Tammy Lauer, research director at InterStudy Publications, is available to speak more about the paper. To speak with Ms. Lauer, please contact Frank Sama at InterStudy Publications at 781-296-2553 or fsama@dresources.com.

About InterStudy Publications

InterStudy Publications, a division of Decision Resources, offers data, directories, and analyses of the ever-evolving managed care industry. InterStudy tracks changes and trends in HMO and PPO services, enrollment, and profitability. Visit InterStudy Publications at www.interstudypublications.com.

About Decision Resources

Decision Resources, Inc., (www.decisionresources.com) is a world leader in research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets. For more than two decades, the company has provided in-depth research on the trends, emerging developments, and market opportunities in the biopharmaceutical and managed health care industries. Companies ranging from global pharmaceutical and biotechnology leaders to start-ups turn to Decision Resources for information, analyses, and advice in making critical research, licensing, and marketing decisions.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

PRNewswire/ -- March 9

SOURCE: InterStudy Publications

Osteoarthritis Drug Market Sales Topped $3.5 Billion in 2002

View Now